Clinical Trials for Pediatric Brain Tumors

3 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TreatmentCOGACNS1022
06/09/2012
ACNS1022 - A Phase II Randomized Trial of Lenalidomide (NSC# 703813, InD# 70116) in Pediatric Patients with Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas
TreatmentCOGACNS0821
10/08/2011
ACNS0821 - Temozolomide with Irinotecan versus Temozolomide, Irinotecan plus Bevacizumab (NSC# 704865, BB-IND# 7921) for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood, A COG Randomized Phase II Screening Trial
TreatmentCOGACNS0831
05/12/2011
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 years.

You do not have JavaScript enabled. This site works better with JavaScript turned on.